Northern Trust’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.9M Sell
652,303
-369,698
-36% -$27.1M 0.01% 1131
2025
Q1
$117M Buy
1,022,001
+6,486
+0.6% +$741K 0.02% 650
2024
Q4
$51.2M Buy
1,015,515
+94,128
+10% +$4.74M 0.01% 1113
2024
Q3
$42.6M Sell
921,387
-10,821
-1% -$501K 0.01% 1130
2024
Q2
$30.3M Sell
932,208
-31,235
-3% -$1.01M 0.01% 1293
2024
Q1
$24.3M Sell
963,443
-128,055
-12% -$3.23M ﹤0.01% 1461
2023
Q4
$35.5M Sell
1,091,498
-191,805
-15% -$6.23M 0.01% 1255
2023
Q3
$35M Sell
1,283,303
-2,318
-0.2% -$63.2K 0.01% 1170
2023
Q2
$28.6M Sell
1,285,621
-65,973
-5% -$1.47M 0.01% 1346
2023
Q1
$29.3M Buy
1,351,594
+327,128
+32% +$7.09M 0.01% 1302
2022
Q4
$20.8M Buy
1,024,466
+27,149
+3% +$551K ﹤0.01% 1491
2022
Q3
$25.6M Sell
997,317
-176
-0% -$4.51K 0.01% 1303
2022
Q2
$23.7M Sell
997,493
-40,470
-4% -$962K 0.01% 1405
2022
Q1
$23.4M Sell
1,037,963
-94,499
-8% -$2.13M ﹤0.01% 1559
2021
Q4
$22.4M Sell
1,132,462
-51,795
-4% -$1.03M ﹤0.01% 1678
2021
Q3
$23.3M Sell
1,184,257
-25,576
-2% -$503K ﹤0.01% 1685
2021
Q2
$26.6M Sell
1,209,833
-34,919
-3% -$768K ﹤0.01% 1687
2021
Q1
$29.6M Sell
1,244,752
-61,309
-5% -$1.46M 0.01% 1541
2020
Q4
$34.2M Sell
1,306,061
-27,683
-2% -$724K 0.01% 1385
2020
Q3
$23.2M Sell
1,333,744
-70,843
-5% -$1.23M 0.01% 1512
2020
Q2
$23.6M Buy
1,404,587
+93,569
+7% +$1.57M 0.01% 1476
2020
Q1
$15.6M Buy
1,311,018
+19,718
+2% +$234K ﹤0.01% 1575
2019
Q4
$15.6M Sell
1,291,300
-7,116
-0.5% -$86.1K ﹤0.01% 1902
2019
Q3
$18.4M Buy
1,298,416
+6,423
+0.5% +$90.8K ﹤0.01% 1744
2019
Q2
$14.4M Buy
1,291,993
+10,825
+0.8% +$121K ﹤0.01% 1909
2019
Q1
$15M Sell
1,281,168
-21,312
-2% -$250K ﹤0.01% 1885
2018
Q4
$17.4M Sell
1,302,480
-8,956
-0.7% -$120K ﹤0.01% 1690
2018
Q3
$18.4M Buy
1,311,436
+63,994
+5% +$897K ﹤0.01% 1848
2018
Q2
$19.6M Buy
1,247,442
+130,839
+12% +$2.06M 0.01% 1795
2018
Q1
$18.4M Buy
1,116,603
+5,342
+0.5% +$87.9K ﹤0.01% 1747
2017
Q4
$20.1M Buy
1,111,261
+3,039
+0.3% +$54.9K 0.01% 1699
2017
Q3
$21.4M Buy
1,108,222
+20,295
+2% +$392K 0.01% 1664
2017
Q2
$12.8M Buy
1,087,927
+164,732
+18% +$1.94M ﹤0.01% 2002
2017
Q1
$10.1M Buy
923,195
+52,274
+6% +$573K ﹤0.01% 2114
2016
Q4
$6.32M Buy
870,921
+14,623
+2% +$106K ﹤0.01% 2390
2016
Q3
$5.57M Buy
856,298
+19,929
+2% +$130K ﹤0.01% 2454
2016
Q2
$4.57M Buy
836,369
+121,955
+17% +$666K ﹤0.01% 2531
2016
Q1
$3.34M Buy
714,414
+20,194
+3% +$94.5K ﹤0.01% 2670
2015
Q4
$3.46M Buy
694,220
+17,690
+3% +$88.1K ﹤0.01% 2703
2015
Q3
$2.54M Buy
676,530
+75,869
+13% +$285K ﹤0.01% 2895
2015
Q2
$3.61M Buy
600,661
+15,478
+3% +$93K ﹤0.01% 2724
2015
Q1
$3.28M Buy
585,183
+11,482
+2% +$64.3K ﹤0.01% 2790
2014
Q4
$1.72M Sell
573,701
-26,875
-4% -$80.6K ﹤0.01% 3190
2014
Q3
$1.61M Sell
600,576
-5,296
-0.9% -$14.2K ﹤0.01% 3233
2014
Q2
$1.7M Sell
605,872
-50,254
-8% -$141K ﹤0.01% 3170
2014
Q1
$2.86M Sell
656,126
-56,498
-8% -$246K ﹤0.01% 2925
2013
Q4
$2.29M Buy
712,624
+13,597
+2% +$43.7K ﹤0.01% 3070
2013
Q3
$1.11M Buy
699,027
+44,156
+7% +$70.2K ﹤0.01% 3305
2013
Q2
$1.13M Buy
+654,871
New +$1.13M ﹤0.01% 3232